VIA Labs Balance Sheet Health
Financial Health criteria checks 6/6
VIA Labs has a total shareholder equity of NT$2.9B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$3.6B and NT$750.1M respectively. VIA Labs's EBIT is NT$156.1M making its interest coverage ratio -4.6. It has cash and short-term investments of NT$1.7B.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | -4.6x |
Cash | NT$1.70b |
Equity | NT$2.85b |
Total liabilities | NT$750.07m |
Total assets | NT$3.60b |
Recent financial health updates
No updates
Recent updates
VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year
Apr 15We Think You Can Look Beyond VIA Labs' (TWSE:6756) Lackluster Earnings
Mar 21VIA Labs' (TWSE:6756) Shareholders Will Receive A Smaller Dividend Than Last Year
Mar 11Robust Earnings May Not Tell The Whole Story For VIA Labs (TPE:6756)
Mar 29VIA Labs (TPE:6756) Is Achieving High Returns On Its Capital
Mar 23Should VIA Labs (TPE:6756) Be Disappointed With Their 84% Profit?
Feb 24Is Weakness In VIA Labs, Inc. (TPE:6756) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 03Should VIA Labs, Inc. (TPE:6756) Be Part Of Your Dividend Portfolio?
Jan 12We Like VIA Labs' (GTSM:6756) Returns And Here's How They're Trending
Dec 17Getting In Cheap On VIA Labs, Inc. (GTSM:6756) Might Be Difficult
Nov 25Financial Position Analysis
Short Term Liabilities: 6756's short term assets (NT$2.2B) exceed its short term liabilities (NT$717.5M).
Long Term Liabilities: 6756's short term assets (NT$2.2B) exceed its long term liabilities (NT$32.6M).
Debt to Equity History and Analysis
Debt Level: 6756 is debt free.
Reducing Debt: 6756 had no debt 5 years ago.
Debt Coverage: 6756 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6756 has no debt, therefore coverage of interest payments is not a concern.